Maria Eugenia Garibotti is Vice President at Analysis Group in Chicago and specializes in the application of economics and statistics to questions arising in antitrust, government investigations, health care, finance, and commercial litigation. In her antitrust work, Dr. Garibotti has evaluated market definition, market structure, competitive effects, and efficiencies in merger reviews and investigations, and has assessed the appropriateness of class certification. She has evaluated allegations of collusive behavior, refusal to deal, exclusive selling arrangements, and non-compete clauses in litigation. Dr. Garibotti has been involved in all phases of the litigation process, including pretrial discovery, preparation of expert reports, class certification, trial preparation, and trial experience. She was part of the Analysis Group team that supported the US Department of Justice (DOJ) challenge to the Anthem-Cigna merger. Dr. Garibotti has analyzed competition issues in the hospital, pharmaceutical, and automobile parts manufacturing industries. Her work in finance has included cases related to residential mortgage-backed securities (RMBS), alleged collusion in financial markets, and investigations of spoofing allegations. Dr. Garibotti also has experience leading teams in the statistical analysis of large datasets.
1838
Le modèle d’enchère de second tour (SSA) est souvent utilisée pour évaluer les effets potentiels sur la concurrence d’une fusion ou d’une acquisition impliquant des marchés sur lesquels les vendeurs et les acheteurs fixent des prix individualisés pour les produits. Cet article traite de (...)
